IPONOVA — India's IPO Intelligence Platform

Goldline Pharmaceutical Limited IPO

Listed · SME · BSE SME

Last updated:  ·  Compiled by IPONOVA Editorial Desk  ·  How we source data

IPO Details

Price Band₹41.00–₹43.00
Lot Size3000 shares
Issue Size₹12 Cr
Open Date12 May 26
Close Date14 May 26
Listing Date19 May 26
ExchangeBSE SME
Subscription840.74x

About Goldline Pharmaceutical Limited

Goldline Pharmaceuticals is engaged in the business of marketing pharmaceutical products under the brand name “Goldline.” The company do not manufacture products, it partner with third-party manufacturers who produce the medicines based on its market research and product specifications, ensuring quality and compliance with regulations. All products are marketed and sold under the Goldline brand through our network of distributors, who supply to retailers and wholesalers. The company currently works with 15 manufacturers and 7 distributors, and it also support hospitals and healthcare providers with procurement and material supply.

Anchor Investor Allotment

Total Investors2
Total Shares732,000
Total Allocation100.00%
Total Investment₹3.15 Cr
Allotment Date15 May 2026
30-Day Lock-in Ends30 Jun 2026
90-Day Lock-in Ends23 Sep 2026
Anchor Investor Name Eq. Shares Allocation % Bid Price Investment Amount 30-Day Lock-in 90-Day Lock-in
Upsurge Opportunities Fund 1 366,000 50.00% ₹43.00 ₹1.57 Cr 30 Jun 2026 23 Sep 2026
Vikasa India EIF I Fund – Share Class P 366,000 50.00% ₹43.00 ₹1.57 Cr 30 Jun 2026 23 Sep 2026
TOTAL (2 investors) 732,000 100.00% ₹3.15 Cr

Lock-in dates calculated from allotment date (30 & 90 calendar days, adjusted to next NSE trading day as per exchange holiday calendar).

Frequently Asked Questions

When does the Goldline Pharmaceutical Limited IPO open and close?
The Goldline Pharmaceutical Limited IPO opens for subscription on 12 May 26. It closes on 14 May 26.
What is the price band of Goldline Pharmaceutical Limited IPO?
The price band of Goldline Pharmaceutical Limited IPO is ₹41.00 to ₹43.00 per share.
What is the minimum lot size for Goldline Pharmaceutical Limited IPO?
The minimum lot size for Goldline Pharmaceutical Limited IPO is 3000 shares, requiring a minimum investment of ₹129,000.
When will Goldline Pharmaceutical Limited list on stock exchanges?
Goldline Pharmaceutical Limited is expected to list on BSE SME on 19 May 26.
How can I check Goldline Pharmaceutical Limited IPO allotment status?
You can check Goldline Pharmaceutical Limited IPO allotment status on IPONOVA after the basis of allotment is finalized, or via the registrar's website using your PAN number, application number, or DP/Client ID.
How to apply for Goldline Pharmaceutical Limited IPO?
You can apply for Goldline Pharmaceutical Limited IPO through your broker's app (Zerodha, Groww, Upstox, etc.) or via UPI-enabled net banking using ASBA. Submit the application during the IPO subscription window with the price within the band ₹41.00 to ₹43.00 per share.

Data Sources & Verification

This page aggregates publicly available data for the Goldline Pharmaceutical Limited IPO from the following authoritative sources:

Subscription, allotment and listing data is refreshed throughout each IPO's issue window directly from the exchanges and registrars listed above. Always read the official offer document (RHP) before applying. For corrections, contact IPONOVA Editorial Desk.

Read our full editorial methodology & sourcing standards →

Disclaimer: IPONOVA is an information platform only. We are not SEBI-registered investment advisors. All data is presented for educational and informational purposes and is sourced from publicly available filings on BSE, NSE and SEBI. Investment in securities market is subject to market risks. Read all related documents carefully before investing. Past performance is not indicative of future returns. Please consult a SEBI-registered investment advisor before making any investment decisions.